Human Influenza A/PR/8/34 (H1N1) Purified Virus, UV-Inactivated

Dudhgaonkar, S., Ranade, S., Nagar, J., Subramani, S., Prasad, D., Karunanithi, P., Srivastava, R., Venkatesh, K., Selvam, S., and Krishnamurthy, P. et al. (2017). Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing Activity. The Journal Of Immunology 198, 1308-1319. https://doi.org/10.4049/jimmunol.1600583

Koopman, G., Mooij, P., Dekking, L., Mortier, D., Nieuwenhuis, I., van Heteren, M., Kuipers, H., Remarque, E., Radoševi?, K., and Bogers, W. (2016). Correlation between Virus Replication and Antibody Responses in Macaques following Infection with Pandemic Influenza A Virus. Journal Of Virology 90, 1023-1033. https://doi.org/10.1128/jvi.02757-15

Pugh, N., Edwall, D., Lindmark, L., Kousoulas, K., Iyer, A., Haron, M., and Pasco, D. (2015). Oral administration of a Spirulina extract enriched for Braun-type lipoproteins protects mice against influenza A (H1N1) virus infection. Phytomedicine 22, 271-276. https://doi.org/10.1016/j.phymed.2014.12.006